Skip to main content
SpringerLink
Log in

Discussion

  • Published:
Journal of Inherited Metabolic Disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  • Abita JP, Blandin-Savoja F, Rey F (1987) Phenylalanine 4-monooxygenase from human liver. Methods Enzymol 142: 27–35.

    Google Scholar 

  • Acosta PB (1996) Recommendations for protein and energy intakes by patients with phenyl-ketonuria. Eur J Pediatr 155 (supplement 1): S121–S124.

    Google Scholar 

  • Arnopp JJ, Lorey FN, Currier RJ et al (1994) Results of screening for phenylketonuria using a lower cuto. value in early collected specimens. Screening 3: 193–199.

    Google Scholar 

  • Berlin CM, Levy HL, Hanley WB (1995) Delayed increase in blood phenylalanine in phenyl-ketonuric children initially classified as mild hyperphenylalaninemia. Screening 4: 35–39.

    Google Scholar 

  • Berry HK, Brunner RL, Hunt MH, White PP (1990) Valine, isoleucine, and leucine. A new treatment for phenylketonuria. Am J Dis Child 144: 539–543.

    Google Scholar 

  • Bick U, Ulrich K, Stober U et al (1993) White matter abnormalities in patients with treated hyperphenylalaninemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr 152: 1012–1020.

    Google Scholar 

  • Bouckaert K, B, Diels M, Raes M (1995) Home monitoring of phenylalanine/ tyrosine in the treatment of phenylketonuria. Abstracts SSIEM Meeting, T oledo, Spain. E5.

  • Breysem L, Smet MH, Johannik K et al (1994) Brain MR imaging in dietary treated phenyl-ketonuria. Eur Radiol 4: 329–331.

    Google Scholar 

  • Burgard P, Rey F, Rupp A, Agadie V, Rey J (1997) Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross sectional study. Pediatr Res 41: 368–374.

    Google Scholar 

  • Celikel R, Davis MD, Dai XP, Kaufman S, Xuong NH (1991) Crystallization and preliminary X-ray analysis of phenylalanine hydroxylase from rat liver. J Mol Biol 218: 495–498.

    Google Scholar 

  • Cleary MA, Walter JH, Wraith GE et al (1994) Magnetic resonance imaging of the brain in phenylketonuria. Lancet 344: 87–90.

    Google Scholar 

  • Cockburn F, Clark BJ (1996) Recommendations for protein and amino acid intake in phenylketonuric patients. Eur J Pediatr 155 (supplement 1): S125–S129.

    Google Scholar 

  • Dantanville VK, Cunningham GC (1973) Effect of feeding on screening for PKU infants. Pediatrics 51: 531–538.

    Google Scholar 

  • Dianzani I, Giannattasio S, De Sanctis L et al (1995) Characterization of phenylketonuria alleles in the Italian population. Eur J Hum Genet 3: 294–302.

    Google Scholar 

  • Doherty LB, Rohr FJ, Levy HL (1991) Detection of phenylketonuria in the very early newborn blood specimen. Pediatrics 87: 240–244.

    Google Scholar 

  • Dotremont H, B, Diels M, Gillis P (1995) Nutritional value of essential amino acids in the treatment of adults with phenylketonuria. J Inher Metab Dis 18: 127–130.

    Google Scholar 

  • Dyer CA, Kendler A, Philibotte T, Gardiner P, Cruz J, Levy HL (1996) Evidence for central nervous system glial cell plasticity in phenylketonuria. J Neuropathol Exp Neurol 55: 795–814.

    Google Scholar 

  • Ferraris S, Spada M, De Sanctis L et al (1996) Early versus late screening for phenylketo-nuria. A metabolic study. In: Levy HL, Hermos RJ, Grady GF, eds. Proceedings of the 3rd Congress of the International Society for Neonatal Screening. IKON/MAP, Watertown, 299–300.

    Google Scholar 

  • Francois B, Willems G, Evrard P (1977) The use of pemoline in the attention deÐ cit syndrome of phenylketonuric patients. ESPR meeting Leuven 1977, abstract in Pediatr Res 1977.

  • Grima B, Lamouroux A, Boni C, Julien JF, Javoy-Agid F, Mallet J (1987) A single human gene encoding multiple tyrosine hydroxylase with di.erent predicted functional characteristics. Nature 326: 707–711.

    Google Scholar 

  • Hanley WB, Denishar H, Preston MA et al (1997) Newborn phenylketonuria (PKU) Guthrie (BIA) screening and early hospital discharge. Early Hum Develop 47: 87–96.

    Google Scholar 

  • Holtzman NA, Mellits ED, Kallman CH (1974) Neonatal screening for phenylketonuria. II: age dependence of initial phenylalanine in infants with PKU. Pediatrics 53: 353–357.

    Google Scholar 

  • Holtzman NA, McCabe ER, Cunningham GC, Berry H (1981) Screening for phenylketonuria. N Engl J Med 304: 1300–1301.

    Google Scholar 

  • Hyland K, Surtess RA, Heales K, Bowron A, Howells D, Smith I (1993) Cerebrospinal Ñuid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population. Pediatr Res 34: 10–14.

    Google Scholar 

  • Issacs CE, Greengard O (1980) The effect of hyperphenylalaninemia on glycine metabolism in developing rat brain. Biochem J 192: 441–448.

    Google Scholar 

  • Jew K, Kan K, Koch R, Cunningham GC (1994) Validity of early collected newborn specimens for phenylketonuria using a fluorometric method. Screening 3: 1–9.

    Google Scholar 

  • Kaufman EE, Driscon BF (1992) Carbon dioxide Ð xation in neuronal and astroglial cells in culture. J Neurochem 58: 258–262.

    Google Scholar 

  • Kaufman S (1977) Phenylketonuria: Biochemical mechanisms. In Agrano. BW and Aprison MH, eds. Advances in Neurochemistry, New York: Plenum Press, 1–132.

    Google Scholar 

  • Lehmann D (1989) Progress in the identiÐ cation of the heterozygote in phenylketonuria. J Pediatr 114: 915–924.

    Google Scholar 

  • Linneweh F, Erlich M (1962) Zuer pathogenese des schwachsinns bein phenylketonuvie. Klin W schr 40: 225–226.

    Google Scholar 

  • LoPachin RM, Aschner M (1993) Glial- neuronal interactions: relevance to neurotoxic mechanisms. T oxicol Appl Pharmacol 118: 141–158.

    Google Scholar 

  • Lorey FW, Cunningham GC (1994) Effect of specimen collection method on newborn screen-ing for PKU. Screening 3: 57–65.

    Google Scholar 

  • Lou HC, Güttler F, Lykkelund C, Bruhn P, Niederwieser A (1985) Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur J Pediatr 144: 17–20.

    Google Scholar 

  • Ludecke B, Bartholome K (1995) Frequent sequence variant in the human tyrosine hydroxylase gene. Hum Genet 95: 716.

    Google Scholar 

  • Martinez A, Knappskog PM, Olafsdottir S et al (1995) Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Biochem J 306: 589–597.

    Google Scholar 

  • McCabe ERB, McCabe L, Mosher GA, Allen RJ, Berman JL (1983) Newborn screening for phenylketonuria: predictive validity as a function of age. Pediatrics 72: 390–398.

    Google Scholar 

  • McDonald JD, Dyer C, Gailis L, Kirby M (1997) Cardiovascular defects among the progeny of mouse phenylketonuria females. Pediatr Res 42: 103–107.

    Google Scholar 

  • Meryash DL, Levy HL, Guthrie R, Warner R, Bloom S, Carr JR (1981) Prospective study of early neonatal screening for phenylketonuria. N Engl J Med 304: 294–296.

    Google Scholar 

  • Okano Y, Wang T, Eisensmith RC et al (1991a) Phenylketonuria missense mutations in the mediterranean. Genomics 9: 96–103.

    Google Scholar 

  • Okano Y, Eisensmith RC, Güttler F et al (1991b) Molecular basis of phenotypic hetero-geneity in phenylketonuria. N Engl J Med 324: 1232–1237.

    Google Scholar 

  • Paans AMJ, Pruim J, Smit JPA, Visser G, Willemsen ATM, Ullrich K (1996) Neurotransmitter positron emission tomographic studies in adults with phenylketonuria, a pilot study. Eur J Pediatr 155 (supplement 1): S78–S81.

    Google Scholar 

  • Patel MS (1974) The relative signiÐ cance of enzymes in the metabolism of the CO2-fixing brain. J Neurochem 22: 717–724.

    Google Scholar 

  • Pietz J, Meyding-Lamadè UK, Schmidt H (1996) Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropterin synthase deficiency. Eur J Pediatr 155 (supplement 1): S69–S73.

    Google Scholar 

  • Ponzone A, Guardamagna O, Ferraris S, Biasetti S, Bracco G, Niederwieser A (1987) Neuro-transmitter therapy and diet in malignant phenylketonuria. Eur J Pediatr 146: 93–94.

    Google Scholar 

  • Ponzone A, Dianzani I, Spada M et al (1993) Prenatal diagnosis in primary hyper-phenylalaninemias. Devel Brain Dysf 6: 158–167.

    Google Scholar 

  • Schuler A, Blau N, Ponzone A (1995) Monoamine oxidase inhibitors in tetrahydrobiopterin deficiency. Eur J Pediatr 154: 997.

    Google Scholar 

  • Scriver CR, Clow CL (1988). Avoiding phenylketonuria: why parents seek prenatal diagnosis. J Pediatr 113: 495–497.

    Google Scholar 

  • Scriver CR, Kaufman S, Eisensmith RC, Woo SLC (1995) The hyperphenylalaninemias. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. T he Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1015–1017.

    Google Scholar 

  • Sinai LN, Kini SC, Casey R, Pinto-Martin JA (1995) Phenylketonuria screening: Effect of early newborn discharge. Pediatrics 96: 605–608.

    Google Scholar 

  • Snyderman SE, Sansaricq C, Norton PM, Castro JV (1981) Plasma and cerebrospinal Ñuid amino acid concentrations in phenylketonuria during the newborn period. J Pediatr 99: 63–67.

    Google Scholar 

  • Spada M, Dianzani I, Bonetti G, Biondi A, Leone L, Ponzone A (1997) Does severity of mutation in the phenylalanine hydroxylase gene influence phenylalanine and tyrosine metabolism in heterozygotes ? J Inher Metab Dis 20 (supplement): P2.2.

    Google Scholar 

  • Trefz FK, Schmidt H, Bartholomè K, Mahle M, Matthis P, Pecht G (1985) Dierential diagnosis and significance of various hyperphenylalaninemias. In Bickel H, Wachtel U, eds. Inherited Diseases of Amino Acid Metabolism. Stuttgard: Georg Thieme Verlag, 86–103.

    Google Scholar 

  • Walraven C, Sorrentino JE, Levy HL, Grady GF (1995) Early newborn specimen: Survey of practices among newborn screening programs in the United States. Screening 4: 1–8.

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Discussion. J Inherit Metab Dis 21 (Suppl 3), 20–52 (1998). https://doi.org/10.1023/A:1017143128132

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1017143128132

Search

Navigation